0001209191-19-037487.txt : 20190617
0001209191-19-037487.hdr.sgml : 20190617
20190617184118
ACCESSION NUMBER: 0001209191-19-037487
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190613
FILED AS OF DATE: 20190617
DATE AS OF CHANGE: 20190617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FETZER OLIVER
CENTRAL INDEX KEY: 0001219018
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31161
FILM NUMBER: 19902322
MAIL ADDRESS:
STREET 1: AUXILIUM PHARMACEUTICALS, INC.
STREET 2: 40 VALLEY STREAM PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001080709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232908305
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-453-7200
MAIL ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-13
0
0001080709
ARENA PHARMACEUTICALS INC
ARNA
0001219018
FETZER OLIVER
C/O ARENA PHARMACEUTICALS, INC.
6154 NANCY RIDGE DRIVE
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2019-06-13
4
A
0
2654
0.00
A
5704
D
Common Stock
2019-06-14
4
S
0
1495
55.8791
D
4209
D
Common Stock
2019-06-14
4
S
0
30
56.64
D
4179
D
Stock Option (right to buy)
56.50
2019-06-13
4
A
0
5000
0.00
A
2026-06-13
Common Stock
5000
5000
D
The amount represents restricted stock units that vest in full on the earliest of June 13, 2020, or the date of Arena's next annual meeting of stockholders. The shares underlying the restricted stock units will be issued upon vesting of the restricted stock units.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.49 to $56.48, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4.
The options vest in 12 equal monthly installments (except as otherwise necessary to avoid vesting of a fractional share) over one year beginning on July 13, 2019, and are exercisable once vested.
/s/ Veronica Vallejo, as Attorney-in-Fact
2019-06-17